Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00006240
First received: September 11, 2000
Last updated: April 27, 2015
Last verified: November 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2001
  Estimated Primary Completion Date: No date given